Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial

Imagem de Miniatura
Arquivos
art_POLI-DE-FIGUEIREDO_Replacement_of_fentanyl_infusion_by_enteral_methadone_decreases_2012_eng.pdf (221.4 KB)
Citações na Scopus
37
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
WANZUITA, Raquel
PFUETZENREITER, Felipe
CAVALCANTI, Alexandre Biasi
WESTPHAL, Glauco Adrieno
Citação
CRITICAL CARE, v.16, n.2, article ID R49, 9p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Patients undergoing mechanical ventilation (MV) are frequently administered prolonged and/or high doses of opioids which when removed can cause a withdrawal syndrome and difficulty in weaning from MV. We tested the hypothesis that the introduction of enteral methadone during weaning from sedation and analgesia in critically ill adult patients on MV would decrease the weaning time from MV. Methods: A double-blind randomized controlled trial was conducted in the adult intensive care units (ICUs) of four general hospitals in Brazil. The 75 patients, who met the criteria for weaning from MV and had been using fentanyl for more than five consecutive days, were randomized to the methadone (MG) or control group (CG). Within the first 24 hours after study enrollment, both groups received 80% of the original dose of fentanyl, the MG received enteral methadone and the CG received an enteral placebo. After the first 24 hours, the MG received an intravenous (IV) saline solution (placebo), while the CG received IV fentanyl. For both groups, the IV solution was reduced by 20% every 24 hours. The groups were compared by evaluating the MV weaning time and the duration of MV, as well as the ICU stay and the hospital stay. Results: Of the 75 patients randomized, seven were excluded and 68 were analyzed: 37 from the MG and 31 from the CG. There was a higher probability of early extubation in the MG, but the difference was not significant (hazard ratio: 1.52 (95% confidence interval (CI) 0.87 to 2.64; P = 0.11). The probability of successful weaning by the fifth day was significantly higher in the MG (hazard ratio: 2.64 (95% CI: 1.22 to 5.69; P < 0.02). Among the 54 patients who were successfully weaned (29 from the MG and 25 from the CG), the MV weaning time was significantly lower in the MG (hazard ratio: 2.06; 95% CI 1.17 to 3.63; P < 0.004). Conclusions: The introduction of enteral methadone during weaning from sedation and analgesia in mechanically ventilated patients resulted in a decrease in the weaning time from MV.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/364
Referências
  1. Amato L., 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004147.
  2. ANAND KJS, 1994, CRIT CARE MED, V22, P334, DOI 10.1097/00003246-199402000-00027
  3. ARNOLD JH, 1990, ANESTHESIOLOGY, V73, P1136, DOI 10.1097/00000542-199012000-00011
  4. Breen D, 2005, CRIT CARE, V9, pR200, DOI 10.1186/cc3495
  5. Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001
  6. Cammarano WB, 1998, CRIT CARE MED, V26, P676, DOI 10.1097/00003246-199804000-00015
  7. DOLE VP, 1965, J AMER MED ASSOC, V193, P646
  8. Epstein J, 1999, CRIT CARE CLIN, V15, P17, DOI 10.1016/S0749-0704(05)70037-3
  9. ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601
  10. Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1
  11. Gowing L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002025.pub4
  12. Gowing L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002024.pub3
  13. Honey BL, 2009, ANN PHARMACOTHER, V43, P1506, DOI 10.1345/aph.1M161
  14. Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020
  15. KATZ R, 1994, CRIT CARE MED, V22, P763, DOI 10.1097/00003246-199405000-00009
  16. KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
  17. Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541
  18. Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002
  19. Lugo RA, 2001, PHARMACOTHERAPY, V21, P1566, DOI 10.1592/phco.21.20.1566.34471
  20. MacIntyre NR, 2001, CHEST, V120, P375, DOI 10.1378/CHEST.120.6_
  21. Meyer M M, 2001, Pediatr Crit Care Med, V2, P329, DOI 10.1097/00130478-200110000-00009
  22. National consensus development panel on effective medical treatment of opiate addiction, 1998, JAMA, V280, P1936
  23. Novaes MAFP, 1999, INTENS CARE MED, V25, P1421, DOI 10.1007/s001340051091
  24. Nseir S, 2010, CRIT CARE, V14, DOI 10.1186/cc8907
  25. Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da
  26. PUNTILLO KA, 1990, HEART LUNG, V19, P526
  27. Robertson R C, 2000, Pediatr Crit Care Med, V1, P119, DOI 10.1097/00130478-200010000-00005
  28. Rozendaal F, 2009, INTENS CARE MED, V35, P291, DOI 10.1007/s00134-008-1328-9
  29. Salluh JIF, 2009, J CRIT CARE, V24, P556, DOI 10.1016/j.jcrc.2009.04.004
  30. SHAPIRO BA, 1995, CRIT CARE MED, V23, P1596, DOI 10.1097/00003246-199509000-00021
  31. Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9
  32. TOBIAS JD, 1994, INTENS CARE MED, V20, P504, DOI 10.1007/BF01711905
  33. TOBIAS JD, 1990, CRIT CARE MED, V18, P1292, DOI 10.1097/00003246-199011000-00024

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/InCor